Authors: Toth, C.¹; Martin, L.²; Morrish, W.³; Coutts, S.¹; Parney, I.¹

Source: Acta Neurologica Scandinavica, Volume 116, Number 4, October 2007 , pp. 259-262(4)

Publisher: Wiley-Blackwell

Abstract:

Toth C, Martin L, Morrish W, Coutts S, Parney I. Dramatic MRI improvement with refractory neurosarcoidosis treated with infliximab.

Acta Neurol Scand 2007: 116: 259-262.

© 2007 The Authors Journal compilation © 2007 Blackwell Munksgaard. Background - 

Neurosarcoidosis is often a devastating, refractory condition without definite pharmacotherapies beyond corticosteroids. Aim - 

To describe a case of steroid-refractory neurosarcoidosis with a marked clinical and radiological response to infliximab. Methods - 

We describe the case of a young female patient with biopsy-proven neurosarcoidosis leading to gait failure. She described significant corticosteroid-related side effects without clinical response to the therapy. Infliximab therapy was considered as a possible rescue medication. Results - 

Within months of starting intravenous infliximab therapy, she regained her ability to walk and magnetic resonance imaging identified significant improvements over a sustained course of infliximab therapy, including loss of enhancing nodules and loss of meningeal enhancement. Conclusion - 

Mounting evidence suggests that infliximab is a valuable pharmacological agent in the management of patients with refractory and disabling neurosarcoidosis. Controlled studies of infliximab in this condition are needed.

Keywords: corticosteroids; infliximab; neurosarcoidosis; sarcoidosis; tumor necrosis factor α inhibitors

Document Type: Research article

DOI: http://dx.doi.org/10.1111/j.1600-0404.2007.00870.x

Affiliations: 1: Department of Clinical Neurosciences 2: Internal Medicine 3: Diagnostic Imaging, University of Calgary and Calgary Health Region, Calgary, AB, Canada

Publication date: 2007-10-01

Related content

• In this: publication
• By this: publisher
• In this Subject: Neurology & Psychiatry
• By this author: Toth, C. ;  Martin, L. ;  Morrish, W. ;  Coutts, S. ;  Parney, I.

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers